Pharmacologic therapy for peripheral arterial disease and claudication
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 36 (6) , 1283-1291
- https://doi.org/10.1067/mva.2002.129654
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized studyJournal of Vascular Surgery, 2002
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- The Effect of Heart Rate Control on Myocardial Ischemia Among High-Risk Patients After Vascular SurgeryAnesthesia & Analgesia, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 CasesAnnals of Internal Medicine, 1998
- Plasma β-Thromboglobulin Levels and Claudication Degrees in Patients with Peripheral Vascular DiseaseAngiology, 1986
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985
- Coronary Artery Disease in Peripheral Vascular PatientsAnnals of Surgery, 1984
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979